首页|固本化痰汤联合常规西药治疗稳定期慢性阻塞性肺疾病患者的效果

固本化痰汤联合常规西药治疗稳定期慢性阻塞性肺疾病患者的效果

扫码查看
目的:观察固本化痰汤联合常规西药治疗稳定期慢性阻塞性肺疾病(COPD)患者的效果.方法:回顾性分析2021—2023年该院收治的60例稳定期COPD患者的临床资料,按照治疗方法不同将其分为观察组和对照组各30例.对照组采用常规西药(布地奈德+异丙托溴铵)治疗,观察组在对照组基础上联合固本化痰汤治疗,两组均连续治疗3个月.比较两组临床疗效,治疗前后肺功能指标[第1秒用力呼气容积(FEV1)、用力肺活量(FVC)、FEV1/FVC]水平、呼吸困难症状[改良英国医学研究委员会呼吸困难指数(mMRC)、慢性阻塞性肺疾病评估测试(CAT)]评分、6 min步行试验(6MWT)距离、T细胞亚群指标(CD4+、CD8+及CD4+/CD8+)水平,以及不良反应发生率.结果:观察组治疗总有效率为90.00%(27/30),高于对照组的66.67%(20/30),差异有统计学意义(P<0.05);治疗后,观察组FEV1、FVC、FEV1/FVC水平均高于对照组,差异有统计学意义(P<0.05);治疗后,观察组mMRC、CAT评分均低于对照组,差异有统计学意义(P<0.05);治疗后,观察组6MWT距离大于对照组,差异有统计学意义(P<0.05);治疗后,观察组CD4+、CD4+/CD8+水平高于对照组,CD8+水平低于对照组,差异均有统计学意义(P<0.05);两组治疗期间均未发生明显不良反应.结论:固本化痰汤联合常规西药治疗稳定期COPD患者可提高治疗总有效率、肺功能指标水平,降低呼吸困难症状评分,增大6MWT距离,改善T细胞亚群指标水平,效果优于单纯常规西药治疗.
Effects of Guben Huatan decoction combined with conventional Western medicine in treatment of patients with stable chronic obstructive pulmonary disease
Objective:To observe effects of Guben Huatan decoction combined with conventional Western medicine in treatment of patients with stable chronic obstructive pulmonary disease (COPD). Methods:The clinical data of 60 patients with stable COPD admitted to this hospital from 2021 to 2023 were retrospectively analyzed. According to different treatment methods,they were divided into observation group and control group,30 cases in each group. The control group was treated with conventional Western medicine (Budesonide+Ipratropium bromide),while the observation group was treated with Guben Huatan decoction on the basis of that of the control group. Both groups were treated continuously for 3 months. The clinical efficacy,the lung function indexes[forced expiratory volume in one second (FEV1),forced vital capacity (FVC),FEV1/FVC]levels,the dyspnea symptoms[modified British medical research council dyspnea index (mMRC),chronic obstructive pulmonary disease assessment test (CAT)]scores,the 6 min walking test (6MWT) distance,and the T cell subsets indexes (CD4+,CD8+and CD4+/CD8+) levels before and after the treatment,and the incidence of adverse reactions were compared between the two groups. Results:The total effective rate of the observation group was 90.00% (27/30),which was higher than 66.67% (20/30) of the control group,and the difference was statistically significant (P<0.05). After the treatment,the levels of FEV1,FVC and FEV1/FVC in the observation group were higher than those in the control group,and the differences were statistically significant (P<0.05). After the treatment,the scores of mMRC and CAT in the observation group were lower than those in the control group,and the differences were statistically significant (P<0.05). After the treatment,the 6MWT distance of the observation group was greater than that of the control group,and the difference was statistically significant (P<0.05). After the treatment,the levels of CD4+and CD4+/CD8+in the observation group were higher than those in the control group,the level of CD8+was lower than that in the control group,and the differences were statistically significant (P<0.05). No obvious adverse reactions occurred in the two groups during the treatment. Conclusions:Guben Huatan decoction combined with conventional Western medicine in the treatment of the stable COPD patients can improve the total effective rate of treatment,the levels of lung function indexes,reduce the scores of dyspnea symptoms,increase the 6MWT distance,and improve the levels of T cell subsets. Moreover,it is superior to simple conventional Western medicine treatment.

Stable periodChronic obstructive pulmonary diseaseGuben Huatan decoctionBudesonideIpratropium bromideLung functionDyspnea symptomT cell subset

陈锴

展开 >

芦溪县中医院呼吸消化科,江西 萍乡 337200

稳定期 慢性阻塞性肺疾病 固本化痰汤 布地奈德 异丙托溴铵 肺功能 呼吸困难症状 T细胞亚群

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(23)